Company Data

Acumen Pharmaceuticals Inc.

Ticker
ABOS
Current Price
$1.31 -5.76%
Market Cap
$79.4M
Price Target
Refer to Report
Volume
272.8K
52wk Range
$0.8551 - $3.36
Advanced Market Data

Overview

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what we believe to be a key underlying cause of Alzheimer’s disease. The company’s lead drug candidate, ACU193, is a subclass monoclonal antibody which selectively targets amyloid-beta oligomers.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy